Horizon Tech Finance Backs Hyperfine with $40M Loan for MRI Expansion
Event summary
- Horizon Technology Finance provided a $40M loan facility to Hyperfine, with $15M initially funded and $25M available for future growth.
- Hyperfine's Swoop® System is the first FDA-cleared portable MRI for brain imaging, targeting ICUs, emergency departments, and smaller hospitals.
- The loan aims to accelerate commercial expansion of the Swoop® System across hospital and office settings, including global markets.
- Horizon cited Hyperfine's strong clinical and economic evidence, along with a second-generation system, as key factors for investment.
The big picture
This deal underscores the growing demand for portable, AI-powered medical imaging solutions that expand access to brain imaging in underserved care settings. Horizon's investment reflects confidence in Hyperfine's ability to disrupt traditional MRI markets, particularly as healthcare systems seek cost-effective, point-of-care diagnostic tools. The $40M facility also highlights the role of venture debt in fueling commercial growth for late-stage medtech companies.
What we're watching
- Commercial Execution
- How Hyperfine will deploy the $40M loan to scale its Swoop® System across diverse care settings and global markets.
- Market Adoption
- Whether the portable MRI system can gain traction in smaller hospitals and neurology offices where traditional MRI is unavailable.
- Competitive Positioning
- The pace at which Hyperfine can differentiate itself in the medtech space amid potential competitors in portable imaging solutions.
Our editorial coverage: